SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Dynavax DVAX -- Ignore unavailable to you. Want to Upgrade?


To: LJM who wrote (39)11/28/2006 8:37:10 PM
From: DewDiligence_on_SI  Respond to of 184
 
It sounds like they will opt for a 3-dose indication in Asia and a 2-dose indication in the West.

Prevalence map of chronic HBV:
investorshub.com



To: LJM who wrote (39)11/29/2006 9:13:53 AM
From: kenhott  Respond to of 184
 
Good stuff!

edit: they will go after 2 dose. The 3rd dose is a problem in the real world.